undamentalytics Newsletter
Sign in

Basel Medical Group Ltd cash flow statement

In fiscal 2026, Basel Medical Group Ltd's operations generated −$494,885 of cash; it spent $193,396 on capital projects, leaving free cash flow of −$688,281.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Jun 20242025Jun 20252026Jun 2026
Cash from operations1,861−3,054−495
Depreciation and amortisation7621,7025,797
Stock-based pay——234
Capital spending6421193
Free cash flow1,856−3,474−688
Free cash flow after stock pay——−922

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BMGL vs NIVFBMGL vs CCMBMGL vs SNDA

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Basel Medical Group Ltd's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Basel Medical Group Ltd.